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Abstract
Objective—Our aim was to determine if NO prevents mitochondrial oxidant damage by mobilizing
intracellular free zinc (Zn2+).
Methods—Zn2+ levels were determined by imaging enzymatically isolated adult rat
cardiomyocytes loaded with Newport Green DCF. Mitochondrial membrane potential (ΔΨm) was
assessed by imaging cardiomyocytes loaded with tetramethylrhodamine ethyl ester (TMRE).
Results—S-nitroso-N-acetylpenicillamine (SNAP) dramatically increased Zn2+, which was
blocked by both ODQ and NS2028, two specific inhibitors of guanylyl cyclase. The protein kinase
G (PKG) inhibitor KT5823 blocked the effect of SNAP while the PKG activator 8-Br-cGMP
mimicked the action of SNAP, indicating that the cGMP/PKG pathway is responsible for the effect
of SNAP. The increased Zn2+ was prevented by 5-hydroxydecanoate (5HD) but was mimicked by
diazoxide, implying that mitochondrial KATP channel opening may account for this effect. Since
chelation of Zn2+ blocked the preventive effect of SNAP on H2O2-induced loss of ΔΨm and
exogenous zinc (1 µM ZnCl2) prevented dissipation of ΔΨm, Zn2+ may play a critical role in the
protective effect of NO. The MEK (mitogen-activated protein kinase or extracellular signal-regulated
kinase) inhibitor PD98059 blocked the preventive effects of SNAP and zinc on ΔΨm, indicating that
extracellular signal-regulated kinase (ERK) mediates the protective effect of both these compounds
on mitochondrial oxidant damage. A Western blot analysis further showed that ZnCl2 significantly
enhances phosphorylation of ERK, confirming the involvement of ERK in the action of Zn2+.
Conclusions—In isolated cardiomyocytes, NO mobilizes endogenous zinc by opening
mitochondrial KATP channels through the cGMP/PKG pathway. In these cells, Zn2+ may be an
important mediator of the action of NO on the mitochondrial death pathway.
Introduction
In addition to its important role as a component of numerous structural proteins, enzymes and
transcriptional factors [1], free or loosely-bound zinc itself has been demonstrated to be
involved in various physiological functions [2]. It plays a crucial role in signal transduction by
modulating cellular signal recognition, second messenger metabolism, protein kinase and
phosphatase activities [3]. In particular, recent studies have proposed that zinc can stimulate
the PI3-kinase/Akt signaling pathway [4–6] and inhibits glycogen synthase kinase-3β
(GSK-3β) [7]. The PI3-kinase/Akt signaling pathway and GSK-3β have been demonstrated to
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play important roles in cardioprotection against ischemia/reperfusion injury [8–10]. Thus, zinc
may be involved in the mechanism of cardioprotection. A recent report further showed that
exogenous zinc suppresses apoptosis in cardiac allografts in a dose-dependent manner [11].
In spite of the important roles of zinc, most of the intracellular zinc is tightly bound to
metallothionein and thus the level of intracellular free zinc is very low. Therefore, either
transient release of zinc from the binding sites to cytosol or supplementation of exogenous free
zinc ion is required to increase cytosolic free or labile zinc. Nitric oxide (NO) has been shown
to induce release of zinc in vascular endothelium [12], hippocampus [13], lung fibroblasts
[14], and islet cells [15]. NO-triggered zinc release has been associated with reduced sensitivity
to lipopolysaccharide (LPS)-induced apoptosis in pulmonary endothelium [16]. NO is
cardioprotective [17], and exogenous zinc can protect hearts from reperfusion injury through
inhibition of oxidative stress [18]. Therefore, it is highly plausible that NO mobilizes
intracellular zinc in cardiomyocytes, which serves as an important mechanism for the
cardioprotective effect of NO.
NO at low concentrations stimulates the synthesis of the second messenger cGMP, which in
turn regulates various cellular functions by activating downstream targets including protein
kinase G (PKG). In contrast, at higher concentrations, NO reacts with O2 to form reactive
nitrogen oxide intermediates such as N2O3[19]. It has been proposed that nitrosylation of
metallothionein by N2O3 is responsible for the mechanism by which NO (at high
concentrations) releases zinc in non-cardiomyocyte cells [12,14,19,20]. However, if NO
induces cardioprotection by releasing zinc, it is unlikely that NO mobilizes zinc through
nitrosylation of metallothionein in heart cells, since we have found that the cGMP/PKG signal
pathway is responsible for the cardioprotective effect of NO [21]. Thus, we chose to determine
if NO can release intracellular zinc through activation of the cGMP/PKG pathway. Since PKG
has been proposed to open mitochondrial KATP channels [22], it is worthy to examine whether
mitochondrial KATP channel opening plays a role in the effect of NO on zinc release.
In the present study, we first tested whether exogenous NO can mobilize intracellular zinc by
imaging isolated rat cardiomyocytes loaded with the Zn2+ specific fluorescence dye Newport
Green DCF. We then investigated the mechanism underlying the effect of NO on zinc release.
Lastly, we examined if NO prevents mitochondrial oxidant damage via a Zn2+-dependent
mechanism.
Materials and Methods
The investigation conforms with the Guide for the Care and Use of Laboratory Animals
published by the US National Institute of Health (NIH Publication No. 85-23, revised 1996).
Chemicals and reagents
Newport Green DCF diacetate and tetramethylrhodamine ethyl ester (TMRE) were purchased
from Molecular Probes (Eugene, OR). Type II collagenase was purchased from Worthington
Biochemical Corporation (Lakewood, NJ). S-nitroso-N-acetylpenicillamine (SNAP), 5-
hydroxydecanoate (5HD), ZnCl2, and N,N,N’,N’-tetrakis-(2-pyridylmethyl)ethylenediamine
(TPEN) were obtained from Sigma (St. Louis, MO). ODQ, NS2028, KT5823, and 8-Br-cGMP
were purchased from Calbiochem (La Jolla, CA). Phospho-ERK antibody was purchased from
Cell Signaling (Beverly, MA).
Isolation of adult rat cardiomyocytes
Male Wistar rats weighing 200–300 g were anesthetized with sodium pentobarbital (100mg/
kg, i.p.). A midline thoracotomy was performed and the heart was removed and rapidly
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mounted on a Langendorff apparatus. The heart was perfused in a non-recirculating mode with
Krebs-Henseleit buffer (37°C) containing (in mM) NaCl 118, NaHCO3 25, KCl 4.7,
KH2PO4 1.2, MgSO4 1.2, CaCl2 1.25, and glucose 10 for 5 min to wash out blood. The buffer
was bubbled with 95 % O2/5 % CO2. Then the heart was perfused with calcium-free buffer
that contained all the above components except CaCl2. After 5 min of calcium-free perfusion,
collagenase (type II) was added to the buffer (0.1 %) and the heart was perfused in a
recirculating mode for ~15 min. The heart was removed from the apparatus and the ventricles
were placed into a beaker containing the calcium-free buffer, and then agitated in a shaking
bath (37°C) at a rate of 50 cycles/min until cells were released. The released cells were
suspended in an incubation buffer containing all the components of the calcium-free buffer, 1
% bovine serum albumin, 30 mM HEPES, 60 mM taurine, 20 mM creatine, and amino acid
supplements at 37°C. Calcium was gradually added to the buffer containing the cells to a final
concentration of 1.2 mM. The cells were filtered through nylon mesh and centrifuged briefly.
Finally the cells were suspended in culture medium M199 for 4 h before experiments.
Measurement of intracellular free zinc
Free zinc (Zn2+) in cardiomyocytes was assessed with Newport Green DCF, a Zn2+-selective
fluorescence dye. The ester form of Newport Green DCF can diffuse across cellular
membranes. Once inside the cells, the ester is hydrolyzed by ubiquitous intracellular esterases
to yield a cell-impermeant fluorescence indicator of Zn2+. Cardiomyocytes cultured in a
specific temperature-controlled culture dish were incubated with 2 µmol/L Newport Green
DCF diacetate in standard Tyrode solution containing (mM) NaCl 140, KCl 6, MgCl2 1,
CaCl2 1, HEPES 5, and glucose 5.8 (pH 7.4) for 20 min. The cells were then mounted on the
stage of an Olympus FV 500 laser scanning confocal microscope. The green Newport Green
DCF was excited with the 488 nm line of an argon-krypton laser and imaged through a 525
nm long-path filter. Stage temperature was maintained at 37°C using a Delta T Open Dish
Systems (Bioptechs, Butler, PA). The images recorded on a computer were quantified using
Image J (NIH).
Confocal imaging of mitochondrial membrane potential (ΔΨm)
To measure ΔΨm, myocytes were loaded with 100 nM tetramethylrhodamine ethyl ester
(TMRE) (Molecular Probe) for 15 min at 37°C. The cells loaded with the dyes were imaged
with a confocal fluorescence microscope (Olympus FV 500). The probes were excited at 543
nm and the red fluorescence image was detected using a 560 nm long path filter. The images
were quantified using Image J.
Western blotting analysis of phosphorylated ERK activity
After exposure to Zn2+ for 10 min, cells were homogenized in ice-cold lysis buffer. Equal
amounts of protein (50 µg) were loaded and eletrophoresed on 10 % SDS-polyacrylamide gel
and transferred to a PVDF membrane. The membrane was probed with a primary antibody that
recognizes phospho-p42/p44 MAPK (phospho-ERKs). To confirm equal loading, the
membrane was stripped and reprobed with an antibody recognizing both phosphorylated and
nonphosphorylated forms of p42/p44 MAPK. The primary antibody binding was detected with
a secondary anti-rabbit antibody and visualized by the ECL method.
Experimental protocol
In the experiments monitoring the change in zinc concentration, the agonists were given
immediately after baseline (time 0’) measurements, whereas the antagonists were given 10 min
prior to the application of the agonists. The measurements were terminated 10 min after the
baseline recordings. In the study evaluating the effect of exogenous Zn2+ on ΔΨm,
cardiomyocytes were exposed to 100 µM H2O2 for 20 min to cause mitochondrial oxidant
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damage. SNAP and ZnCl2 were given 10 min before exposure to H2O2. Fluorescence intensity
was determined from 5 to 10 cells at each time point.
Statistical Analysis
Data are expressed as mean ± SEM. Statistical significance was determined using either one-
way ANOVA followed by Tukey’s test or Student t-test. A value of p < 0.05 was considered
as statistically significant.
Results
In the present study, intracellular free zinc (Zn2+) was detected with the Zn2+ -selective
fluorescence dye Newport Green DCF. Newport Green DCF has moderate zinc-binding
affinity (KD = 1 µM) but is essentially insensitive to Ca2+ or Mg2+, making this probe useful
for measuring intracellular Zn2+ in various experimental conditions[23–25]. As shown in
Figure 1A, no change in Newport Green DCF fluorescence over time was seen in untreated
cardiomyocytes. In contrast, cells exposed to the exogenous NO donor SNAP (20 µM) for 10
min had a dramatic increase in Newport Green DCF fluorescence (170.5 ± 10.6 % of baseline,
n = 16), indicating that NO can mobilize intracellular Zn2+ in isolated rat cardiomyocytes.
Importantly, this increase was completely reversed by subsequent addition of the membrane-
permeable Zn2+ selective chelator TPEN (10 µM), confirming that this increase is due to
changes in Zn2+ concentration rather than other ions.
To investigate the mechanisms by which NO induces Zn2+ release, ODQ, a potent and selective
inhibitor of NO-sensitive guanylyl cyclase, was applied to test if it could alter the effect of
SNAP on Newport Green DCF fluorescence. Figure 1A shows that ODQ (5 µM) was able to
prevent the effect of SNAP, implying that cGMP is responsible for the mobilization of Zn2+
by NO. The involvement of cGMP in the action of SNAP was confirmed by further experiments
in which the action of SNAP was impeded by another specific and irreversible inhibitor of
guanylyl cyclase NS2028 (1 µM). To rule out the possibility that SNAP mobilizes Zn2+ by
nitrosylating metallothionein, we examined if dithiothreitol (DTT), a thiol reducing agent
known to reverse S-nitrosylation [26], could block the effect of SNAP. Figure 1A shows that
SNAP still enhances the green fluorescence intensity in the presence of DTT, suggesting that
SNAP-induced Zn2+ mobilization is not mediated by nitrosylation of metallothionein. Figure
1B shows Newport Green DCF fluorescence data 10 min after the baseline measurement
expressed as % of the baseline. Both ODQ (109.6 ± 6.0 % of baseline, n = 6) and NS2028
(106.8 ± 3.3 % of baseline, n = 6) blocked the effect of SNAP on Zn2+ mobilization, indicating
that cGMP is essential for the action of NO on Zn2+ release.
PKG is an important downstream target of cGMP, and our previous data have shown that it is
involved in the cardioprotective effect of SNAP [21]. To determine whether PKG activation
is required, the effect of SNAP on zinc release was assessed in the presence of KT5823, a
highly specific cell-permeable inhibitor of PKG. As shown in Figure 2, 1 µM KT5823
prevented the SNAP-induced increase in Newport Green DCF fluorescence (107.1 ± 9.5 % of
baseline, n = 10), indicating that the activation of PKG may contribute to the Zn2+-releasing
effect of NO. Since PKG can activate mitochondrial KATP channels in cardiomyocytes [21,
27], it is worthy to test if mitochondrial KATP channel activation is implicated in the action of
SNAP. Interestingly, the effect of SNAP was aborted by 500 µM 5HD (103.9 ± 2.6 % of
baseline, n = 10), a specific closer of mitochondrial KATP channels, suggesting that SNAP may
release intracellular Zn2+ by opening mitochondrial KATP channels. Further experiments
showed that the selective mitochondrial KATP channel opener diazoxide (50 µM) mimicked
the effect of SNAP by enhancing Newport Green DCF fluorescence (165.3 ± 21.3 % of
baseline, n = 6), confirming the crucial role of mitochondrial KATP channel.
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If PKG is critical for the action of SNAP, direct activation of PKG should result in the release
of Zn2+ thus mimicking the action of SNAP. As shown in Figure 3, 8-Br-cGMP (200 µM), a
cell-permeable PKG activator, markedly enhanced Newport Green DCF fluorescence 10 min
after treatment (145.4 ± 5.9 % of baseline, n = 10), an effect that was reversible by addition of
TPEN (96.9 ± 6.2, n = 5). These observations confirm that the activation of PKG mediates the
action of NO on Zn2+ release. Similar to the observation described in Figure 2, both KT5823
(106.0 ± 5.5 % of baseline, n = 6) and 5HD (113.1 ± 2.8 % of baseline, n = 7) abolished the
effect of 8-Br-cGMP on Zn2+ release.
Zinc has been reported to have both anti-apoptotic and anti-oxidative effects. In order to
determine the potential physiological role of the NO-mobilized Zn2+ in cardiomyocytes, the
effect of exogenous Zn2+ on mitochondrial oxidant damage was assessed in cardiomyocytes.
ZnCl2 (1 µM) significantly increased intracellular free zinc. Figure 4A shows that cells treated
with 1 µM ZnCl2 for 10 min in the presence of the zinc ionophore pyrithione (4 µM) exhibited
a marked increase in Newport Green DCF fluorescence. Figure 4B presents the summarized
data, and shows a significant increase in the fluorescence intensity (148.8 ± 8.4 % of baseline,
n = 6) produced by 1 µM ZnCl2.
In this study, it was noticed that the staining pattern of Newport Green DCF resembled one
with the mitochondrial specific dye TMRE. As shown in Figure 5A, the overlay image indicates
the two fluorescence probes are colocalized, suggesting that Newport Green DCF may be
localized in either inside or in close proximity to mitochondria. To rule out the possibility that
the changes in Newport Green DCF fluorescence was due to alterations of ΔΨm,
cardiomyocytes loaded with Newport Green DCF and TMRE were treated with SNAP in the
presence of Carbonyl cyanide m-chlorophenylhydrazone (CCCP). Figure 5B shows that SNAP
was able to significantly enhance Newport Green DCF fluorescence intensity despite the loss
of ΔΨm by CCCP, suggesting that the Zn2+ signal is independent of changes in ΔΨm. Further
experiments showed that CCCP alone also did not increase the Newport Green DCF intensity
(Figure 5C).
Figure 6 shows that 100 µM H2O2 (20 min) caused a marked decrease in red TMRE
fluorescence (32.4 ± 8.8 % of baseline, n = 6), indicating dissipation of ΔΨm. In contrast, 20
µM SNAP attenuated the loss of ΔΨm (80.0 ± 9.9 % of baseline, n = 6), an effect that was
partially blocked by TPEN (51.4 ± 4.5 % of baseline, n = 6), indicating that NO can prevent
the mitochondrial death pathway via Zn2+. In support, 1 µM ZnCl2 in the presence of pyrithione
(4 µM) given 10 min prior to the exposure to H2O2 also prevented the loss of the red
fluorescence (89.2 ± 4.8 % of baseline, n = 12), indicating that exogenous Zn2+ successfully
prevents mitochondrial oxidant damage. Since SNAP-induced cardioprotection against cardiac
infarction was mediated by ERK [21], it is interesting to examine whether blockade of the ERK
pathway can alter the effect of zinc. As shown in Figure 6, the effect of ZnCl2 on ΔΨm was
partially but significantly blocked by PD98059 (67.7 ± 7.0 % of baseline, n = 6), indicating
that ERK may play a role in the protective effect of Zn2+. Figure 6 also shows that the protective
effect of SNAP was blocked by PD98059 (54.9 ± 8.0 % of baseline, n = 5), corroborating the
crucial role of ERK in NO-induced cardioprotection that is mediated by Zn2+. To further
confirm the role of ERK in the action of Zn2+, the effect of ZnCl2 on ERK activity was
determined. As shown in Figure 7, cardiomyocytes treated with 1 µM ZnCl2 for 10 min in the
presence of pyrithione revealed a significant increase in phosphorylation of both ERK1 (220.4
± 39.2 % of control, n = 5) and ERK2 (287.4 ± 59.5 % of control, n = 5), indicating that ERK
may serve as a downstream signal of Zn2+.
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This is the first study to demonstrate that exogenous NO mobilizes intracellular zinc via cGMP/
PKG signal pathway and the opening of mitochondrial KATP channels in cardiomyocytes. It
appears that Zn2+ plays an important role in the protective effect of NO on mitochondrial
dysfunction caused by oxidant stress, and that the activation of ERK by phosphorylation may
serve as a downstream signal leading to the protective effect of Zn2+.
It is well known that the major intracellular Zn2+ binding protein is metallothionein [28].
Nitrosylation of metallothionein has been proposed to be the mechanism by which NO at high
doses (2 mM SNOC or 0.2 and 2 mM DETA/NO) releases Zn2+ [12,14,19,20]. In contrast to
the well-characterized effect of NO on Zn2+ release in these cells, little is known about the
impact of NO on Zn2+ dynamics in cardiomyocytes. In the present study, we have demonstrated
that SNAP at a low dose (20 µM) markedly increased Zn2+ release, which was abolished by
inhibition of either guanylyl cyclase or PKG. This finding suggests that even at a low
concentration NO can trigger Zn2+ release through activation of the cGMP/PKG pathway. The
involvement of this pathway was also confirmed by the observation that the cell-permeable
PKG activator 8-Br-cGMP-induced Zn2+ release. We further demonstrated that SNAP-induced
Zn2+ release was not altered by DTT, a thiol-reducing agent known to reverse S-nitrosylation
[26], indicating that the mechanism of Zn2+ release in cardiomyocytes reported here is novel
and distinct from the above-mentioned premise that the nitrosylation of metallothionein is
responsible for NO-induced Zn2+ release. Although the reason for this discrepancy is unclear,
it should be noted that compared to those previous studies in which high doses of NO donors
were used, we treated cardiomyocytes with a low dose (20 µM) of SNAP. It is well accepted
that NO at low concentrations activates soluble guanylyl cyclase to synthesize cGMP, which
in turn activates downstream targets such as PKG. Recently, we [21] and others [29] have also
found that the activation of PKG is crucial for the cardioprotective effect induced by low doses
of SNAP. Thus, it is conceivable that the low dose of SNAP used in this study activated PKG,
which in turn induced Zn2+ release.
As to the mechanism by which activated PKG causes Zn2+ release, we hypothesize that the
mitochondrial KATP channel opening is a potential initiating event that leads to the release of
Zn2+, since the activation of PKG has been shown to open the mitochondrial KATP channels
[21,22,27]. In this study, 5HD completely abolished the SNAP-induced release of Zn2+ and
diazoxide-mobilized Zn2+, indicating that the mitochondrial KATP channel opening is a
required step for the release of Zn2+. Furthermore, the observation that 5HD also blocks the
release of Zn2+ induced by the PKG activator 8-Br-cGMP suggests that the mitochondrial
KATP channel opening is a downstream event that is needed for the release of Zn2+. Further
studies are needed to dissect the detailed mechanisms whereby the mitochondrial KATP channel
opening is linked to Zn2+ release. Since the mitochondrial KATP channel opening is recognized
as the central mechanism for the cardioprotective effect of ischemic preconditioning [30], the
release of Zn2+ by the opening of this channel may serve as an important mechanism for
cardioprotection.
In the present study, we found that the Zn2+ fluorescence probe Newport Green DCF was co-
localized with the mitochondrial membrane potential dye TMRE in cardiomyocytes under
normoxic conditions, indicating that Newport Green DCF (thus detected Zn2+) is located inside
or in close proximity to the mitochondria. Although the mitochondrial KATP channel opening
leads to the release of Zn2+, it remains unknown whether Zn2+ was released from mitochondria.
Further studies using recognized mitochondria-selective Zn2+ probes (when available) are
needed to ascertain the origin of Zn2+ mobilized by NO.
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Zinc can modulate apoptosis [2]. In both in vitro and in vivo models, Zn2+ supplementation
prevents apoptosis [31,32]. A recent report showed that exogenous Zn2+ suppresses apoptosis
in cardiac allografts in a dose-dependent manner [11]. The anti-oxidant effect and a direct
suppression of caspase-3 may contribute to the anti-apoptotic effect of Zn2+ [2,33].
Interestingly, in pulmonary endothelial cells SNAP reduced lipopolysaccharide-induced
apoptosis in a zinc-dependent fashion [16]. Since mitochondria are closely associated with
both oxidant stress and the development of apoptosis, and NO has been shown to protect
cardiomyocytes by modulating mitochondrial functions [34], it is plausible that NO prevents
the mitochondrial death pathway by mobilizing intracellular zinc. In the present study, we have
demonstrated that SNAP attenuates the loss of ΔΨm caused by H2O2, which was partially but
significantly blocked by the Zn2+ chelator TPEN, suggesting that the protective effect of NO
is mediated by Zn2+. In support, exogenous ZnCl2 increased intracellular Zn2+ concentration
and prevented the collapse of ΔΨm caused by H2O2. This result suggests that the Zn2+
mobilized by NO may play an important role in preventing mitochondrial oxidant damage.
Since Zn2+ induces mitochondrial dysfunctions in hepatocytes [35] and in neurons [36], we
examined whether Zn2+ could alter ΔΨm in cardiomyocytes. ZnCl2 (1 µM) had no effect on
ΔΨm under normoxic condition (data not shown), indicating that Zn2+ in low concentrations
does not induce mitochondrial dysfunction in cardiomyocytes.
As to the mechanisms by which Zn2+ protects mitochondria, we propose that ERK may serve
as one of the downstream signals leading to the protection, since the ERK inhibitor PD98059
partially, but significantly, blocked the action of Zn2+ on the mitochondrial dysfunction. The
involvement of ERK in the effect of Zn2+ was further supported by the observation that
exogenous Zn2+ enhances activation of ERK. In agreement with the current finding, Zn2+ was
shown to activate ERK in human bronchial epithelial cells [37], PC12 cells [38], and colorectal
cancer cell [39]. ERK has been demonstrated to be an essential survival signal blocking cell
death caused by ischemia/reperfusion injury [40], and we have demonstrated that ERK plays
a role in the protective effect of SNAP on ischemia/reperfusion injury in rat hearts [21]. Also,
there is evidence that the activation of the ERK pathway can inhibit apoptosis [41]. Therefore,
it is reasonable to propose that NO-mobilized Zn2+ activates ERK, which in turn protects
mitochondria from oxidant stress. However, it should be noted that the inhibition of ERK
activation partially but not completely blocked the protective effect of Zn2+, implying that
some additional mechanisms other than the activation of ERK may also be important. As
mitochondria have been involved in cell death caused both by necrosis and apoptosis [42],
understanding the impact of Zn2+ on mitochondrial dysfunction will help explain the
cardioprotection of NO in both necrosis and apoptosis.
In summary ( Figure 8), we have demonstrated for the first time that exogenous NO mobilizes
intracellular Zn2+ via a cGMP/PKG dependent signal pathway in rat cardiomyocytes, and
prevents the mitochondrial death pathway via Zn2+. The opening of mitochondrial KATP
channel may play a role in the effect of NO on Zn2+ release. The critical role of Zn2+ in the
action of NO on mitochondrial oxidant damage may provide novel insights into the mechanism
underling the cardioprotective effects of NO.
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A, Confocal fluorescence images of Newport Green DCF at baseline and 10 min after exposure
to 20 µM SNAP in rat cardiomyocytes. SNAP markedly enhanced the fluorescence intensity,
which was reversible by addition of TPEN (10 µM). Both ODQ and NS2028 but not
dithiothreitol (DTT) blocked the action of SNAP. B, Summarized data for Newport Green DCF
fluorescence intensity 10 min after exposure to SNAP expressed as percentage of baseline. *
p < 0.05 vs. control; # p < 0.05 vs. SNAP.
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Newport Green DCF fluorescence intensity 10 min after exposure to 20 µM SNAP in rat
cardiomyocytes. Both the PKG inhibitor KT5823 and the mitochondrial KATP channel closer
5HD abolished the effect of SNAP on Newport Green DCF fluorescence. The mitochondrial
KATP channel opener diazoxide mimicked the action of SNAP by enhancing the fluorescence
intensity. * p < 0.05 vs. control; # p < 0.05 vs. SNAP.
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Newport Green DCF fluorescence intensity 10 min after exposure to 200 µM 8-Br-cGMP
expressed as percentage of baseline. The fluorescence intensity was dramatically increased by
8-Br-cGMP, indicating that the direct activation of PKG can mimic SNAP’s action to release
zinc. Both the PKG inhibitor KT5823 and the mitochondrial KATP channel closer 5HD
abolished the effect of 8-Br-cGMP. * p < 0.05 vs. control; # p < 0.05 vs. 8-Br-cGMP
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A, Confocal fluorescence images of Newport Green DCF at baseline and 10 min after exposure
to ZnCl2 in rat cardiomyocytes. ZnCl2 (1 µM) markedly increased intracellular free zinc
concentration. B, Summarized data for Newport Green DCF fluorescence intensity 10 min
after exposure to ZnCl2 expressed as percentage of baseline. * p < 0.05 vs. control.
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A, Representative confocal fluorescence images of cardiomyocytes loaded with both TMRE
and Newport Green DCF. The overlay image indicates co-localization of the two dyes. B,
Confocal fluorescence images of cardiomyocytes loaded with both Newport Green DCF and
TMRE. Cardiomyocytes were treated with SNAP in the presence of CCCP. C, Confocal
fluorescence images of cardiomyocytes loaded with both Newport Green DCF and TMRE.
Cardiomyocytes were treated with CCCP.
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Summarized data for TMRE fluorescence intensity 20 min after exposure to H2O2 (100 µM).
Confocal fluorescence images of TMRE were collected at baseline and 20 min after exposure
to H2O2 in rat cardiomyocytes. Compared to the control, both SNAP (20 µM) and ZnCl2 (1
µM ) prevented TMRE fluorescence reduction, indicating that both NO and zinc can prevent
dissipation of ΔΨm caused by oxidant stress. The action of SNAP was partially but significantly
blocked by both TPEN and PD98059, implying that NO protects mitochondria via Zn2+ and
ERK. The protective effect of zinc was blocked by PD98059 (20 µM), indicating an
involvement of ERK in the action of zinc. * p < 0.05 vs. control; # p < 0.05 vs. SNAP; § p <
0.05 vs. ZnCl2.
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Western blotting analysis of phospho-ERK activity in rat cardiomyocytes. ZnCl2 (1 µM, 10
min) dramatically increase ERK phosphorylation. * p < 0.05 vs. control.
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Signaling mechanisms whereby NO mobilizes intracellular zinc and prevents the
mitochondrial oxidant damage.
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